Evidence map›Paper›PMID 31428983›Full record

ArticleJournal of general internal medicine2020

Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study.

Hector R Perez, Michele Buonora, Chinazo O Cunningham, Moonseong Heo, Joanna L Starrels

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2022
    Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hector R PerezMontefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. heperez@montefiore.org.
Michele BuonoraMontefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Chinazo O CunninghamMontefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Moonseong HeoDepartment of Public Health Sciences, College of Behavioral, Social and Health Sciences, Clemson University, Clemson, SC, USA.
Joanna L StarrelsMontefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Albert Einstein College of Medicine · USClemson University · USMontefiore Medical Center · US

Funding

Prescription opioid use, misuse, disorders and HIV outcomesR01DA039046 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STARRELS, JOANNA L. · 2015 to 2018
$2.4M
Developing and pilot testing an intervention to increase opioid tapering in primary careK23DA044327 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PEREZ, HECTOR RUBEN · 2017 to 2021
$995k
Mentoring researchers on drug abuse and HIVK24DA036955 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CUNNINGHAM, CHINAZO · 2014 to 2019
$911k
Mentoring Junior Investigators to Tackle the Opioid EpidemicK24DA046309 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STARRELS, JOANNA L. · 2018 to 2023
$876k
NIDA NIH HHS K23 DA044327NIDA NIH HHS K24 DA036955NIDA NIH HHS K24 DA046309NIDA NIH HHS R01 DA039046
6 · The paper itself

Abstract

backgroundOpioid tapering is increasingly utilized by providers to decrease risks of chronic opioid therapy, but it is unknown whether tapering is associated with termination of care.

objectiveTo determine whether patients taking chronic opioid therapy who experienced opioid tapers were at greater risk of subsequently terminating their care compared with those who were continued on their doses.

designRetrospective cohort study of patients in a large, urban health system between 2008 and 2012 with 2 years of follow-up.

participantsAdult patients prescribed a stable baseline dose of chronic opioid therapy of at least 25 morphine milligram equivalents per day during a baseline year. MAIN MEASURES: An opioid taper during an exposure year, defined as a reduction in the average daily dose of at least 30% from the baseline dose in both of the two 6-month periods in the year following the baseline year. Opioid dose continuation was defined as any increase in dose, no change in dose, or any decrease up to 30% compared with baseline dose in the exposure year. The primary outcome was termination of care, defined as no outpatient encounters in the health system, in the year following the exposure year. KEY

resultsOf 1624 patients on chronic opioid therapy, 207 (15.5%) experienced an opioid taper and 78 (4.8%) experienced termination of care. Compared with opioid dose continuation, opioid taper was significantly associated with termination of care (AOR 4.3 [95% CI 2.2-8.5]).

conclusionsOpioid taper is associated with subsequent termination of care. These findings invite caution and demonstrate the need to fully understand the risks and benefits of opioid tapers.

Indexed as

Analgesics, OpioidChronic PainAdultHumansOutpatientsRetrospective StudiesAnalgesics, Opioidcare managementchronic painpatient safetyprimary care

Identifiers

PMID31428983
PMCPMC6957663
OpenAlexW2969233749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.